Human papillomavirus infection in women attended at a cervical cancer screening service in Natal, Brazil

Brazilian Journal of Microbiology

Volumn 39, Issue 3, 2008, Pages 573-578

  Fernandes, Thales Allyrio Araújo De Medeiros ^b   Meissner, Rosely De Vasconcellos ^a   Bezerra, Laelson Freire ^c   De Azevedo, Paulo Roberto Medeiros ^a   Fernandes, José Veríssimo ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO NORTE   (Brazil)

^b DEPARTAMENTO DE FÍSICA   (Brazil)

^c Luiz Antonio Hospital   (Brazil)

Author keywords

Cervical cancer; Epidemiology; Human papillomavirus; Prevalence; Risk factors

Indexed keywords

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 54349117725     PISSN: 15178382     EISSN: 16784405     Source Type: Journal    
DOI: 10.1590/S1517-83822008000300031     Document Type: Article

References (26)

1. Baseman, J.G.; Koutsky, L.A. (2005). The epidemiology of human papillomavirus infections. J. Clin. Virol., 32 Suppl 1, S16-24.
2. Bosch, F.X.; de Sanjosé, S. (2003). Chapter 1: Human Papillomavirus and Cervical Cancer - Burden and Assessment of Causality. J. Natl. Cancer Inst. Monographs, 31, 3-13.
3. Bosch, F.X.; Lorincz, A.; Muñoz, N.; Meijer, C.J.L.M.; Shah, K.V. (2002). The causal relation between human papillomavirus and cervical cancer. J. Clin. Pathol., 55, 244-265
4. Câmara, G.N.L.; Cerqueira, D.M.; Oliveira, A.P.G.; Silva, E.O.; Carvalho, L.G.S.; Martins, C.R.F. (2003). Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic lesions in the Federal District of Brasil. Mem. Inst. Oswaldo Cruz, 98 (7), 879-883.
5. Castle, P.E.; Schiffman, M.; Herrero, R.; Hildesheim, A.; Rodriguez, A.C.; Bratti, M.C.; Sherman, M.E.; Wacholder, S.; Tarone, R.; Burk, R.D. (2005). A prospective study of age trends in cervical human papillomavirus acquisition and persistence in Guanacaste, Costa Rica. J. Infect. Dis., 191 (11), 1808-1816.
6. Clifford, G.; Franceschi, S.; Diaz, M.; Muñoz, N.; Villa, L.L. (2006). Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine, 24 Suppl 3, S26-34.
7. Clifford, G.M.; Gallus, S.; Herrero, R.; Muñoz, N.; Sniiders, P.J.F.; Vaccarella, S.; Anh, P.T.; Ferreccio, C.; Hieu, N.T.; Matos, E.; Molano, E.; Rajkumar, R.; Ronco, G.; Sanjose, S.; Shin, H.R.; Sukvirach, S.; Thomas, J.O.; Tunsakul, S.; Meijer, C.J.; Franceschi, S. IARC HPV Prevalence Surveys Study Group. (2005a). Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a polled analysis. Lancet., 366, 991-998.
8. Clifford, G.M.; Rana, R.K.; Franceschi, S.; Smith, J.S.; Gough, G.; Pimenta, J.M. (2005b). Human Papillomavirus Genotype Distribution in Low-Grade Cervical Lesions: Comparison by Geographic Region and with Cervical Cancer. Cancer Epidemiol. Biomarkers Prev., 14, 1157-1164.
9. Da Silva, T.T.; Guimarães, M.L.; Barbosa, M.I.C.; Pinheiro, M.F.G.; Maia, A.F. (2006). Identificação de tipos de papilomavírus e de outros fatores de risco para neoplasia intra-epitelial cervical. Rev. Bras. Ginecol. Obst., 28 (5), 285-291.
10. Ferreccio, C.; Prado, R.B.; Luzoro, A.V.; Ampuero, S.L.; Snijders, P.J.F.; Meijer, C.J.L.M.; Vaccarella, S.V.; Jara, A.T.; Puschel, K.I.; Robles, S.C.; Herrero, R.; Franceschi, S.F.; Ojeda, J.M. (2004). Population-Based Prevalence and Age Distribution of Human Papillomavirus Among Women in Santiago, Chile. Cancer Epidemiol. Biomarkers Prev., 13 (12), 2271-2276.
11. Frega, A.; Stentella, P.; de Ioris, A.; Piazze, J.J.; Fambrini, M.; Marchionni, M.; Cosmi, E.V. (2003). Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence. Cancer Lett., 196 (2), 127-134.
12. Gahlinger, P.M.; Abramson, J.H. (1995). Computer programs for epidemiologic analysis: PEPI. Stone Mountain, USD.
13. Herrero, R.; Hildesheim, A.; Bratti, C.; Sherman, M.E.; Hutchinson, M.; Morales, J.; Balmaceda, I.; Greenberg, M.D.; Alfaro, M.; Burk, R.D.; Wacholder, S.; Plummer, M.; Schiffman, M. (2000). Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J. Natl. Cancer Inst., 92, 464-474.
14. Jacobs, M.V.; de Roda Husman, A.M.; van den Brule, A.J.; Snijders, P.J.; Meijer, C.J.; Walboomers, J.M. (1995). Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J. Clin. Microbiol., 33, 901-905.
15. Kjaer, S.K.; Svare, E.I.; Worm, A.M.; Walboomers, J.M.; Meijer, C.J.; van den Brule, A.J. (2000). Human papillomavirus infection in Danish female sex workers. Decreasing prevalence with age despite continuously high sexual activity. Sex. Transm. Dis., 27 (8), 438-445.
16. Lorenzato, F.; Ho, L.; Terry, G.; Singer, A.; Santos, L.C.; Batista, R.L.; Lubambo, T. (2000). The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). Int. J. Gynecol. Cancer, 10 (2), 143-150.
17. Manos, M.M.; Ting, T.; Wright, D.K.; Lewis, A.J.; Broker, T.R.; Wolinsky, S.M. (1989). The use of polymerase chain reaction amplification for the detection of genital human papillomavirus. Cancer Cell. Mol. Diagnost. Hum. Cancer, 7, 209-214.
18. Muñoz, N.; Bosch, F.X.; de Sanjosé, S.; Herrero, R.; Castellsagué, X.; Shah, K.V.; Snijders, P.J.F.; Meijer, C.J.L.M. (2003). Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer. N. Engl. J. Med., 348, 518-527.
19. Naud, P.; Matos, J.; Hammes, L.; Stuckzynski, J.; Brouwers, K.; Magno, V.; Dias, E.; Crusius, P.; d'Avila, A.; Campos, C.; Costa, M.; Hoblik, M.; Marc, C.; Marroni, R.; Syrjanen, K. (2006). Factors predicting intermediate endpoints of cervical cancer and exposure to human papillomavirus (HPV) infections in young women screened as potential targets for prophylactic HPV vaccination in south of Brazil. Eur. J. Obstet. Gynecol. Reprod. Biol., 124 (1), 110-118.
20. Rabelo-Santos, S.H.; Zeferino, L.; Villa, L.L.; Sobrinho, J.P.; Amaral, R.G.; Magalhães, A.V. (2003). Human papillmavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiânia, Brazil. Mem. Inst. Oswaldo Cruz, 98 (2), 181-184.
21. Ronco, G.; Ghisetti, V.; Segnan, N.; Snijders, P.J.; Gillio-Tos, A.; Meijer, C.J.L.M.; Merletti, F.; Franceschi, S. (2005). Prevalence of human papillomavirus infection in women in Turin, Italy. Eur. J. Cancer, 41 (2), 297-305.
22. Saiki, R.K.; Scharf, S.; Faloona, F.; Mullis, K.B.; Horn, G.T.; Erlich, H.A.; Arnheim, N. (1985). Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science, 230, 1350-1354.
23. Sambrook, J.; Russel, D.W. (2001). Molecular cloning: a laboratory manual. 3rd. ed., Cold Spring Harbor Laboratory Press, New York.
24. Trottier, H.; Franco, E.L. (2006). The epidemiology of genital human papillomavirus infection. Vaccine, 24 Suppl 1, S1-15.
25. Trottier, H.; Mahmud, S.; Costa, M.C.; Sobrinho, J.P.; Duarte-Franco, E.; Rohan, T.E.; Ferenczy, A.; Villa, L.L.; Franco, E.L. (2006). Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol. Biomarkers Prev., 15 (7), 1274-1280.
26. Walboomers, J.M.; Jacobs, M.V.; Manos, M.M.; Bosch, F.X.; Kummer, J.A.; Shah, K.V.; Snijders, P.J.F.; Peto, J.; Meijer, C.J.L.M.; Muñoz, N. (1999). Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189 (1), 12-19.